Clinical

Dataset Information

0

An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer


ABSTRACT: This phase I trial studies how well an imaging agent called I-124 M5A works in detecting CEA-positive colorectal cancer that has spread to the liver. I-124 M5A is a monoclonal antibody, called M5A, linked to a radioactive substance called I-124. M5A binds to CEA-positive cancer cells and may, through imaging scans, be able to detect liver metastases by picking up signals from I-124.

DISEASE(S): Stage Ivb Colorectal Cancer Ajcc V8,Stage Ivc Colorectal Cancer Ajcc V8,Stage Iva Colorectal Cancer Ajcc V8,Stage Iv Colorectal Cancer Ajcc V8,Carcinoma,Colorectal Carcinoma Metastatic In The Liver,Metastatic Colorectal Carcinoma,Colorectal Neoplasms

PROVIDER: 2308884 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 90389 | ecrin-mdr-crc
| 2390827 | ecrin-mdr-crc
2013-08-18 | E-GEOD-48302 | biostudies-arrayexpress
2013-07-20 | E-GEOD-49040 | biostudies-arrayexpress
2007-06-06 | E-SMDB-3992 | biostudies-arrayexpress
2009-06-26 | GSE16801 | GEO
2024-04-13 | E-MTAB-12594 | biostudies-arrayexpress
2023-02-03 | GSE213828 | GEO
2013-07-20 | E-GEOD-49041 | biostudies-arrayexpress
2021-08-24 | GSE182623 | GEO